Swissmedic Issues Recall of Locametz 25 mcg Multidose Kits for Radiopharmaceutical Use
Swissmedic has announced a precautionary recall of specific batches of Locametz 25 mcg Multidose Kits for radiopharmaceutical applications. Clinical teams,…
Europe
europe updates on medical device regulation and quality.
258 articles
258 articles in Europe
Latest News
Latest News
Swissmedic Expands Therapeutic Indication for Ryeqo®
On 17 December 2025, Swissmedic announced an important regulatory update concerning the medication Ryeqo®. The approval marks an extension of…
Latest News
Swissmedic Approves Temporary Distribution of Hibidil Sterile Solution in French Packaging
On December 17, 2025, Swissmedic approved a temporary measure allowing the distribution of Hibidil sterile solution in French-language packaging within…
Latest News
Critical Updates: Field Safety Alerts Issued for Medical Devices (8–12 December 2025)
Medical device professionals should be aware of the latest Field Safety Notices (FSNs) published between 8–12 December 2025. These updates…
Latest News
Critical Recall Alert: Prednisolone 5mg Soluble Tablets by Activase Pharmaceuticals
Activase Pharmaceuticals Limited has issued a Class 3 medicines recall for two specific batches of Prednisolone 5mg Soluble Tablets as…
Latest News
Swissmedic Announces Therapeutic Expansion for Blenrep®: Key Updates for Regulatory Teams
On December 13, 2025, Swissmedic announced the extension of the therapeutic indication for Blenrep®, signaling a significant development in its…
Latest News
Urgent Recall: Hameln Pharma Ltd Issues Safety Notice for Clarithromycin 500mg Infusion Powder
Hameln Pharma Ltd has issued a Class 2 Medicines recall for specific batches of Clarithromycin 500 mg powder for concentrate…
Latest News
Swissmedic Alerts on Compromised Originality Seals for Urapidil Stragen i.v. – Critical Notice for Healthcare Providers
On December 12, 2025, Swissmedic issued an important notice regarding compromised originality seals on specific packaging units of Urapidil Stragen…
Latest News
Swissmedic Announces Appointment of Two New Members to Agency Council for 2026–2029 Term
On December 12, 2025, Swissmedic announced the addition of two new members to its Agency Council, marking a crucial step…
Latest News
Critical Updates: Field Safety Notices Issued from 1 to 5 December 2025
Clinical, quality, and regulatory teams should take note of the latest Field Safety Notices issued during the first week of…
Latest News
Safety Notice: Flamingo Pharma UK Updates Required in Amitriptyline Hydrochloride PILs
Flamingo Pharma UK Ltd has issued a Class 4 Medicines Defect Notification for Amitriptyline Hydrochloride tablets. The Patient Information Leaflets…
Latest News
Swissmedic Announcement: Expanded Indication for Sarclisa®
Swissmedic has issued an important update for healthcare and regulatory professionals regarding Sarclisa®. An extension of the therapeutic indication has…
Loading more articles…